ArticleCureus2026
Complement Component 4D (C4d) Staining in Lupus Nephritis: Correlating Renal Histopathological Features With Clinical Presentation and Short-Term Outcomes.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Systemic lupus erythematosus frequently manifests as lupus nephritis (LN), a major cause of renal morbidity. Standard markers lack specificity, making renal biopsy essential. Complement component 4D (C4d) staining, reflecting classical complement activation, correlates with histopathological lesions and outcomes. This study evaluates C4d's clinical relevance in biopsy-proven LN, emphasizing its potential in detecting disease severity. Materials & methods This observational study at Bangabandhu Sheikh Mujib Medical University (BSMMU), Dhaka, conducted from September 2021 to August 2022, enrolled 45 adults with biopsy-proven LN; 43 completed follow-up. Participants were selected based on revised American College of Rheumatology (ACR) criteria and underwent thorough clinical evaluation, serological testing, and ultrasound-guided renal biopsy. Histopathological assessment followed the International Society of Nephrology and the Renal Pathology Society (ISN/RPS) 2003 classification, including activity and chronicity indices and immunohistochemical C4d staining. Follow-up investigations were performed at two and six months. Results Among the 43 patients with LN (mean age 28.4 ± 7.7 years; 86% female subjects), 42 (97.7%) patients had hematuria and 25 (58.1%) had renal impairment. Class IV was the predominant histological subtype in 18 (41.9%) cases, with mild chronicity in 20 (71.4%) cases. C4d deposition, primarily arteriolar in 24 (55.8%) cases, correlated significantly with Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores and histological activity indices (p<0.05). There is a significant relationship between C4d intensity and SLEDAI score, highlighting the prognostic utility of C4d staining. Conclusion The present study identifies C4d staining to be associated with active renal damage and higher SLEDAI scores, reflecting immune-mediated injury. These findings highlight its value as a potential marker that may enhance current histological assessment. Therefore, staining with C4d on renal biopsy may be emphasized for early detection of severity in patients with lupus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.